ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CMSH China Medical

52.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
China Medical LSE:CMSH London Ordinary Share KYG211081164 ORD USD0.005 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 52.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

China Medical Share Discussion Threads

Showing 426 to 446 of 450 messages
Chat Pages: 18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
27/9/2010
11:01
deleted.
posted on new thread

2ngawang
27/9/2010
10:55
assuming I've got the symbol for CMSH in HK right (867) the new thread will be here:-
dasv
26/9/2010
11:41
Yes, thanks Mattjos, had been wondering how the IPO was progressing.

Happy to see they priced the shares at the top end - that's around 42p per share equivalent, so not too great a gap between that and the current UK price. Looking forward to Tues with great interest.

penpont
25/9/2010
20:26
many thanks mattjos
dasv
24/9/2010
16:31
droid.

Yes I am still in. h-l transferred my shares to my new TDW sipp this week before the deadline. they pulled their finger out to do this as myother holdings have not gone across yet. I also have CMSH shares in my TDW dealing account.

I noticed the WCC thread and will be creating a new thread. When it's up I'll put a link in.

Isn't the HK float on the 28th?

edit: yep:-

"Trading of the shares is expected to commence on Tuesday, 28 September 2010 on the Main Board of the HKEx under the stock code 867. Shares will be traded in board lots of 800 shares. "

dasv
24/9/2010
16:25
Dasv. Are you still in this. If so, any chance of a new thread using the Hongkong epic which I think is 867 ? I was thinking along the lines of the new West China Cement one ( 2233 ).
droid
16/9/2010
23:49
Some quite interesting stuff here:



China Medical System aims to raise $129 million from Hong Kong IPO

By Lillian Liu | 10 September 2010

The pharmaceutical services company fights for investor attention along with 10 other Chinese companies that plan to launch small to mid-size share sales in Hong Kong or the US this month.
China Medical System Holdings, a Chinese pharmaceutical services company, is looking to raise up to HK$1 billion ($129 million) from a Hong Kong initial public offering to fund its business expansion.

The company is joining more than 10 other Chinese companies with plans to launch small to mid-size new share sales in the Hong Kong or US equity markets this month, suggesting there will be a fight for investor appetite for mid-cap Chinese enterprises.

The competition will be even tougher thanks to bigger names such as AIA Group and Xinjiang Goldwind, which are expected to resume the IPOs that they called off earlier in the year. The pan-Asian insurer halted its plans for a share sale when it became the subject of a takeover bid from Prudential. However, the bid eventually failed, depriving its owners of much-needed capital from a potential acquisition. Goldwind postponed its earlier offering due to the poor market condition at the time.

Given China Medical's unique business model -- it makes very few products itself, but engages in marketing and promotion of prescription drugs in China -- investors will need to expand their research beyond the company to get the full picture of how China's drug market works.

"People tend to mix it up with Sinopharm (a Chinese drug distributor). But [these two companies] operate in different parts of the chain. The margin for the marketing and promotion companies is significantly higher [than for the distribution companies] because they make profits from charging pharmaceutical companies," said a source.

Shenzhen-based China Medical is offering 17.8% of the company, or 200 million shares, at between HK$3.6 and HK$5.06 apiece. That means the company could raise between HK$720 million and HK$1.01 billion. The deal comes with a 15% greenshoe option which, if fully exercised, would allow the company to raise HK$828 million to HK$1.16 billion by selling an additional 30 million shares. The base deal is made up of 170 million primary shares and 30 million secondary shares.

The indicated price range translates to 12.5 times to 17.6 times projected earnings for 2011, according to sources.

The company started bookbuilding yesterday. The final price will be fixed on September 20 (US time) and the trading debut on the Hong Kong exchange is scheduled for September 28. UBS is managing the transaction.

Founded in 1995, China Medical helps promote and raise awareness of pharmaceutical products among physicians; it offers pharmaceutical companies that lack the capability to commercialise or promote their products on their own, a way to efficiently bring these products to market. With a market share of 18% in 2009, China Medical is the largest pharmaceutical services company focusing on marketing, promotion and sale of prescription drugs in China, according to its preliminary IPO prospectus.

The company made a profit of $60.9 million last year and $37.2 million in the first six months in 2010. It plans to use the proceeds to increase its marketing and promotion network.

Another medical player, Shanghai-based MicroPort Scientific, which makes equipment for keyhole surgery, is said to be seeking about $130 million from a Hong Kong IPO this month. Credit Suisse and Piper Jaffray are managing that sale.

Last September, Sinopharm Group, the largest distributor of pharmaceutical products in China, raised $1.13 billion in a popular Hong Kong IPO, which received massive demand from both institutions and retail investors.

Sinopharm sold 545.67 million new H-shares representing 25% of the company. Strong demand enabled it to fix the price at the top of the HK$12.25 to HK$16 range, valuing the company at 25.5 times its projected earnings for 2010. The stock closed at HK$31 yesterday -- 93.7% above its IPO price.


Copyright © 2010 Haymarket Media. All rights reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorisation.
Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions.

penpont
14/9/2010
18:56
HK Daily, Under News of '6 IPOs Grab Capital of HKYuan 100 Billion During Rising Market Conditions'. 15th Sept.2010

而今085;開始招股340;康哲(0867)每手800股入á80;費約4,088元,有別044;早前該股044;投資者推171;會的初步307;股文件所$848;的每手500股,被Ú39;到為何上ţ19;每手買賣Û34;位時,保Ŗ14;人瑞銀回ú33;稱,考慮ų97;售情況後ʌ92;認為「800股是較ઽ1;確選擇」Ӎ0;
消息281;,即使計450;15%的Ū29;額配售權ʌ92;該股國際ų97;售仍超額ű26;3倍,西京237;資董事長129;央斥1億元5469;購該;股,9981;少長;線基7329;認購;,據2862;,新;加坡0027;權基;金GIC亦有意#469;購。

MingPao Daily. 15th Sept. On IPO info on 867.

康哲(0867)-9月15日至9月20日307;股;9月28日上市ʍ07;入場費2555.5元;;集6039;7.2至10.12億元5307;保薦;人為9790;銀;;收票4892;為渣;打銀4892;(香଄7;)、東亞銀Ŝ92;及交通銀Ŝ92;

--------------------------------------------

HKDaily
The entrance fee for IPO 867 will be HK$4088 at 800 shares per deal minimum. When asked why had the minimum deal been increased to 800 than its previously stated 500 shares in the preliminary document, the guarantor Swiss Bank spokesman replied, "800 is a more appropriate number after consideration on the placement statistics."

The information source says the international pre-ipo fund raising was 3 times oversubscribed taking into consideration the extra 15% allotment allowed. "West Capital" or Xi-Jing's executive chairman led in investing one billion HKYuan in current offering; since this, many Funds with long term objectives followed suit in investing in 867. From what we hear, the Singaporean Mutual Trust Fund GIC is interested.
--------------------------------------------

MingPao Daily

Official public IPO will take place on 28th Sept. 2010. From the 15th to 20th Sept. will be the pre-IPO roadshow and fund raising period for 867. Entrance fee at HKYuan 2555.50; new capital to be raised is estimated to be HKYuan7.2 to 10.12 Billion. Guarantor is Swiss Bank. Ticket collectors are Communication Bank, HK Standard Chartered Bank and East Asia Bank.

--------------------------------------

2ngawang
13/9/2010
09:43
thanks for that 2ngawang
dasv
12/9/2010
18:10
Found this:

Ming Pao Daily HK, 10th Sept. 2010
Author is Mr. Lee, Hai/Ocean of C.A.S.H. (Celestial Asia) Finance House/Broker.

康哲"277;業(00867.HK)計劃發行2Ï40;股。公司Ĭ01;倫敦轉至Ɖ21;港上市,ý07;股價介乎3.6-5.06元,將集Ũ39;規模7.2-10.12億803;。公司利992;其中33.3%用於;擴大9986;品組;合;16.8%建設生產ॼ8;房,高毛࠷3;是公司發ऻ7;的特徵,๮2;去三年一௥2;維持在60%以9978;,我;們看2909;其未;來發3637;,建;議投6039;者認;購。

Pre-IPO HK:0867 plans to issue 2 billion shares. This company has delisted from London and to be listed in HK at a range of HKYuan 3.6 to 5.06. The projected capital to be raised is an impressive HKYuan 7.2 to 10.12 Billion. the company has earmarked one third of new capital to expand their product line and re-organization. 16.8% is to be used on selecting a factory/warehouse site for production purposes. High profits has been a trait pattern of this plc with the last three years' records maintaining above 60% each year.

We take a favourable stance on this stock and expect its future to perform well. We suggest 'buy' for investors.

-------------------------------------------------

2ngawang
10/9/2010
13:02
Sold my UK holding due to lowly priced HK IPO. Probably CMSH wants to ensure a successful debut and had therefore lowered its current share price relative to NAV to achieve and appease HK-ers and to raise funds but it's at a detriment to UK faithfuls.

Can buy back in HK.

2ngawang
10/9/2010
12:28
Stegrego - you can't sell online either with HL.

they are not issuing certificates for SIPP holdings. Deadline is 24th Sep with them. They have my account details at TDW. I doubt they'll transfer on time. On the 24th they will be selling all remaining CMSH shares from HL holders so I wouldn't expect a good price that day for selling. Maybe a technical buying opp in the TDW account though.

dasv
10/9/2010
11:58
Dasv,

They will be only taking sells now at HL and you will have to sell out or take certificates, probably by the end of next week.

stegrego
10/9/2010
10:16
Hargreaves Lansdown really really suck.

Check this out.

(I have already instructed them to transfer my SIPP out).

"Online dealing not available
We are unable to deal China Medical System Hldgs Ltd ORD USD0.10 online. For further information on placing a deal or for a current price please call our dealers on 0117 980 9800.

Please choose one of the options below to continue.

Back
Search again
Cancel
"

dasv
10/9/2010
09:53
yes I am disappointed existing holders aren't getting a look in.
dasv
10/9/2010
08:23
while the share price did briefly fall below 30p in July the current placing does look a bit of a give away, an underwritten rights issue would have been fairer to existing shareholders but would have cost the company more. I hope it isnt one of those times when the family of existing management have the chance to buy at the vastly discounted price, I don't suppose we will even get a look in.
3800

3800
09/9/2010
21:43
thanks for the info dasv. That looks lowly priced - eq to 30-42p. Let's hope there is no significant earnings dilution here....
penpont
09/9/2010
15:47
DJ China Medical Sys. Response to press speculation

TIDMCMSH

RNS Number : 4560S

China Medical System Holdings Ltd

09 September 2010

+------------------------------------+------------------------------------+
| For Immediate release | 9 September 2010 |
+------------------------------------+------------------------------------+

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATION.

China Medical System Holdings Ltd

("CMS" or "the Company")

Response to press speculation

The Board of China Medical System Holdings Limited (AIM: CMSH) notes the recent press speculation regarding a possible fundraising and confirms that it is conducting a roadshow to certain institutional investors in connection with its proposed listing of the Company's shares on the main board of The Hong Kong Stock Exchange Limited (the "Proposed Listing"). Any offer will be subject to investor demand and market conditions and there is no guarantee that it will proceed.

At the EGM, shareholders approved resolutions relating to, among others, cancellation of the admission of the shares of the Company to trading on AIM (the "Delisting") conditional upon the Proposed Listing occurring and on the same day as the date of the Proposed Listing. The resolution approving the Delisting allows the Delisting to occur within a three month period from 20 August to 19 November 2010.It is currently expected that the Proposed Listing will occur on 28 September 2010 (Tuesday). Should there be a change in the expected date of the Proposed Listing and the date of the Delisting, the Company will make an announcement regarding such change as soon as practicable and in any event not later than ten clear business days in advance of the final date of Delisting.

For further information, please contact:

+---------------------------------------+--------------------+
| China Medical System Holdings Ltd | + (852) 2369 3889 |
+---------------------------------------+--------------------+
| Vincent Hui | |
+---------------------------------------+--------------------+
| Seymour Pierce Limited (Nominated | + 44 (0)20 |
| Adviser) | 7107 8344 |
+---------------------------------------+--------------------+
| Chris Howard / Catherine Leftley | |
+---------------------------------------+--------------------+

The information contained in this document is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia). These materials do not contain, constitute or form part of an offer to sell or the solicitation of an offer to purchase securities in the United States or in any other jurisdiction. The securities referred to herein (the "Securities") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration under the Securities Act except pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will be no public offer of the Securities in the United States or in the United Kingdom.

This notice does not constitute an offer to subscribe for any securities of the Company. Any investment decision in relation to securities offered pursuant to the Proposed Listing should be taken solely in reliance on the information provided in any applicable offer document the Company may issue. Notes for editors

China Medical System Holdings Limited

China Medical System Holdings Limited is listed on the Alternative Investment Market (AIM) of the London Stock Exchange with the ticker symbol "CMSH". For further information, please visit www.chinamedicalsystem.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND ESTIMATES

This announcement contains certain forward-looking statements and estimates with respect to the financial condition, results of operations and business of the Group and certain plans and objectives of the Board of the Company with respect thereto. These forward-looking statements and estimates can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'will', 'may', 'should', 'would', 'could' or other words of similar meaning. These statements are based on estimates, assumptions and assessments made by the Board in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe appropriate. By their nature, forward-looking statements and estimates involve risk and uncertainty, because they relate to events and depend on circumstances that will or may occur in the future and the factors described in the context of such forward-looking statements in this announcement could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements or estimates. Although the Group and the persons who have accepted responsibility for the information contained in this announcement believe that the expectations reflected in their respective forward-looking statements or estimates are reasonable, they can give no assurance that such expectations will prove to have been correct and the Group and the persons who have accepted responsibility for the information contained in this announcement therefore caution you not to place undue reliance on these forward-looking statements or estimates which speak only as at the date of this announcement.

OVERSEAS JURISDICTIONS

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. Such persons (including, without limitation, nominees, trustees and custodians) should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions.

This information is provided by RNS

The company news service from the London Stock Exchange

SPCDMGGLKLZGGZM

(END) Dow Jones Newswires

09-09-10 1544GMT

standtall
09/9/2010
09:39
Thanks dasv! REALLY helpful! :-)
bearfoot
09/9/2010
08:37
Does anyone know the actual market cap and eps based on the trading update today ("company expects to make in excess of US$30 (ie £20m or so) million this year")??? The market cap, according to ADVFN, is just £25 million....!!!!!!! I assume the ADVFN market cap of £25m (and all the other per share compartivies) have not been adjusted for the share split (20 for 1) earlier this year..... Is this right? If so, does this mean that the market cap is a whopping £500m (20 x £25m)??? No wonder they are off to the Hong Kong market especially with a 10% spread and poor liquidity here in the UK.
bearfoot
09/9/2010
08:28
taking off now.. share price appreciation ahead of HK listing. Look what WCC share price did after listing in HK .

WCC in HK:-

dasv
Chat Pages: 18  17  16  15  14  13  12  11  10  9  8  7  Older

Your Recent History

Delayed Upgrade Clock